Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Morphology and immunophenotyping issues in the integrated diagnosis of hematologic disorders of elderly patients.

Literature DB >> 24881039

Morphology and immunophenotyping issues in the integrated diagnosis of hematologic disorders of elderly patients.

Gina Zini¹, Marie C Béné².

Abstract

Entities: Disease Species

Mesh：

Year: 2014 PMID： 24881039 PMCID： PMC4040890 DOI： 10.3324/haematol.2014.106724

Source DB: PubMed Journal: Haematologica ISSN： 0390-6078 Impact factor: 9.941

Keyword Cloud
References

× No keyword cloud information.

19 in total

Review 1. Immunophenotyping of acute leukemia and lymphoproliferative disorders: a consensus proposal of the European LeukemiaNet Work Package 10.

Authors: M C Béné; T Nebe; P Bettelheim; B Buldini; H Bumbea; W Kern; F Lacombe; P Lemez; I Marinov; E Matutes; M Maynadié; U Oelschlagel; A Orfao; R Schabath; M Solenthaler; G Tschurtschenthaler; A M Vladareanu; G Zini; G C Faure; A Porwit
Journal: Leukemia Date: 2011-01-21 Impact factor: 11.528

Review 2. Monoclonal B-cell lymphocytosis: right track or red herring?

Authors: Paolo Ghia; Federico Caligaris-Cappio
Journal: Blood Date: 2012-03-14 Impact factor: 22.113

Review 3. Optimizing reduced-intensity conditioning regimens for myeloproliferative neoplasms.

Authors: Aravind Ramakrishnan; Brenda M Sandmaier
Journal: Expert Rev Hematol Date: 2010-02-01 Impact factor: 2.929

4. Improved outcome for children with acute lymphoblastic leukemia: results of Dana-Farber Consortium Protocol 91-01.

Authors: L B Silverman; R D Gelber; V K Dalton; B L Asselin; R D Barr; L A Clavell; C A Hurwitz; A Moghrabi; Y Samson; M A Schorin; S Arkin; L Declerck; H J Cohen; S E Sallan
Journal: Blood Date: 2001-03-01 Impact factor: 22.113

Review 5. Treatment of older patients with chronic lymphocytic leukemia: key questions and current answers.

Authors: Tait Shanafelt
Journal: Hematology Am Soc Hematol Educ Program Date: 2013

6. Early clearance of peripheral blasts measured by flow cytometry during the first week of AML induction therapy as a new independent prognostic factor: a GOELAMS study.

Authors: F Lacombe; C Arnoulet; M Maynadié; E Lippert; I Luquet; A Pigneux; N Vey; O Casasnovas; F Witz; M C Béné
Journal: Leukemia Date: 2008-11-06 Impact factor: 11.528

Morphology and immunophenotyping issues in the integrated diagnosis of hematologic disorders of elderly patients.

Review 1. Immunophenotyping of acute leukemia and lymphoproliferative disorders: a consensus proposal of the European LeukemiaNet Work Package 10.

Review 2. Monoclonal B-cell lymphocytosis: right track or red herring?

Review 3. Optimizing reduced-intensity conditioning regimens for myeloproliferative neoplasms.

4. Improved outcome for children with acute lymphoblastic leukemia: results of Dana-Farber Consortium Protocol 91-01.

Review 5. Treatment of older patients with chronic lymphocytic leukemia: key questions and current answers.

6. Early clearance of peripheral blasts measured by flow cytometry during the first week of AML induction therapy as a new independent prognostic factor: a GOELAMS study.

7. Anemia prevalence in a home visit geriatric population.

8. Therapy-related acute myeloid leukemia and myelodysplastic syndrome: a clinical and morphologic study of 65 cases.

Review 9. Ageing populations: the challenges ahead.

Review 10. Managing myelodysplastic symptoms in elderly patients.